Mahmood Akhtar Kayani

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

End Stage Renal Disease

Monoclonal Antibody

Dna Damage Response

Top Venues

Future oncology (London, England)

Molecular biology reports

Molecular genetics and genomics : MGG

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Rizwan, Ishrat Mahjabeen, Nida Sarosh Ashraf, Maryam Arshad, Muhammad Shahbaz Haris, Mahmood Akhtar Kayani
Dysregulation of exosomal miRNAs and their related genes in head and neck cancer patients. Future oncology (London, England) (2024)
Nida Sarosh Ashraf, Ishrat Mahjabeen, Muhammad Zahid Hussain, Muhammad Rizwan, Maryam Arshad, Azhar Mehmood, Muhammad Shahbaz Haris, Mahmood Akhtar Kayani
Role of exosomal miRNA-19a / 19b and PTEN in brain tumor diagnosis. Future oncology (London, England) (2023)
Maria Fazal Ul Haq, Muhammad Zahid Hussain, Ishrat Mahjabeen, Zertashia Akram, Nadia Saeed, Rabia Shafique, Sumaira Fida Abbasi, Mahmood Akhtar Kayani
Oncometabolic role of mitochondrial sirtuins in glioma patients. PloS one 18 (2) (2023)
Maria Fazal Ul Haq, Muhammad Zahid Hussain, Ishrat Mahjabeen, Zertashia Akram, Nadia Saeed, Rabia Shafique, Sumaira Fida Abbasi, Mahmood Akhtar Kayani
Oncometabolic role of mitochondrial sirtuins in glioma patients. PloS one 18 (2) (2023)
Aamir Parvez, Ishrat Mahjabeen, Azhar Mehmood, Asad Ullah Khan, Asif Nisar, Mahmood Akhtar Kayani
Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. Molecular genetics and genomics : MGG (2023)
Rabia Shafique, Ishrat Mahjabeen, Kashaf Bibi, Farah Kalsoom, Muhammad Rizwan, Nida Sarosh Ashraf, Azhar Mehmood, Maria Fazal Ul Haq, Sumaira Fida Abbasi, Nadia Saeed, Mahmood Akhtar Kayani
miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers. Future oncology (London, England) (2023)
Maria Fazal Ul Haq, Muhammad Zahid Hussain, Ishrat Mahjabeen, Zertashia Akram, Nadia Saeed, Rabia Shafique, Sumaira Fida Abbasi, Mahmood Akhtar Kayani
Oncometabolic role of mitochondrial sirtuins in glioma patients. PloS one 18 (2) (2023)
Maria Fazal Ul Haq, Muhammad Zahid Hussain, Ishrat Mahjabeen, Zertashia Akram, Nadia Saeed, Rabia Shafique, Sumaira Fida Abbasi, Mahmood Akhtar Kayani
Oncometabolic role of mitochondrial sirtuins in glioma patients. PloS one 18 (2) (2023)
Maria Fazal Ul Haq, Muhammad Zahid Hussain, Ishrat Mahjabeen, Zertashia Akram, Nadia Saeed, Rabia Shafique, Sumaira Fida Abbasi, Mahmood Akhtar Kayani
Oncometabolic role of mitochondrial sirtuins in glioma patients. PloS one 18 (2) (2023)
Nadia Saeed, Ishrat Mahjabeen, Farzana Hakim, Muhammad Zahid Hussain, Azhar Mehmood, Asif Nisar, Malik Waqar Ahmed, Mahmood Akhtar Kayani
Role of Chk1 gene in molecular classification and prognosis of gastric cancer using immunohistochemistry and LORD-Q assay. Future oncology (London, England) 18 (25) (2022)
Maria Fazal Ul Haq, Mahmood Akhtar Kayani, Taaha Arshad, Raja Abdul Hadi Anwar, Nadia Saeed, Rabia Shafique, Sumaira Fidda Abbasi, Malik Waqar Ahmed, Ishrat Mahjabeen
Genetic interactions of mitochondrial sirtuins in brain tumorigenesis. Future oncology (London, England) 18 (5) (2022)
Ishrat Mahjabeen, Sadeeq Sheshe, Tehmina Shakoor, Muhammad Zahid Hussain, Muhammad Rizwan, Azher Mehmood, Muhammad Shahbaz Haris, Falak Fazal, Ayesha Burki, Mahmood Akhtar Kayani
Role of genetic variations of DNA damage response pathway genes and heat-shock proteins in increased head and neck cancer risk. Future oncology (London, England) (2022)
Syeda Sana, Mahmood Akhtar Kayani
Role of Vitamin D deficiency and mRNA expression of VDR and RXR in haematological cancers. Molecular biology reports 48 (5) (2021)
Ishrat Mahjabeen, Yusra Maqsood, Ramsha Abbasi, Malik Waqar Ahmed, Mahmood Akhtar Kayani
Polymorphism in miRNA target sites of CEP-63 and CEP-152 ring complex influences expression of CEP genes and favors tumorigenesis in glioma. Future oncology (London, England) 17 (25) (2021)
Kinza Zoraiz, Muhammad Attique, Shanzah Shahbaz, Malik Waqar Ahmed, Mahmood Akhtar Kayani, Ishrat Mahjabeen
Deregulation of mitochondrial sirtuins and OGG1-2a acts as a prognostic and diagnostic biomarker in leukemia. Future oncology (London, England) 17 (27) (2021)
Javeria Qadir, Syeda Kiran Riaz, Kiran Taj, Natasha Sattar, Namood-E Sahar, Jahangir Sarwar Khan, Mahmood Akhtar Kayani, Farhan Haq, Muhammad Faraz Arshad Malik
Increased YAP1 expression is significantly associated with breast cancer progression, metastasis and poor survival. Future oncology (London, England) 17 (21) (2021)
Asad Ullah Khan, Ishrat Mahjabeen, Muhammad Arif Malik, Muhammad Zahid Hussain, Sarfraz Khan, Mahmood Akhtar Kayani
Modulation of brain tumor risk by genetic SNPs in PARP1gene: Hospital based case control study. PloS one 14 (10) (2019)
Kashif Bashir, Romana Sarwar, Soma Saeed, Ishrat Mahjabeen, Mahmood Akhtar Kayani
Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma. PloS one 13 (9) (2018)